Interpretable Artificial Intelligence to Optimise Imatinib Use After Resection in Localised Gastrointestinal Stromal Tumours
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Interpretable artificial intelligence to optimise use of imatinib after resection in patients with localised gastrointestinal stromal tumours: an observational cohort study
Lancet Oncol 2024 Jul 05;[EPub Ahead of Print], D Bertsimas, G Antonios Margonis, S Sujichantararat, A Koulouras, Y Ma, CR Antonescu, MF Brennan, J Martín-Broto, S Tang, P Rutkowski, ME Kreis, K Beyer, J Wang, E Bylina, P Sobczuk, A Gutierrez, B Jadeja, WD Tap, P Chi, S SingerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.